Last week, U.S. Congressman Tim Walz (D-MN) – plus nine of his Democratic colleagues on the House Committee on Veterans Affairs – requested scientists at the Veterans Affairs (VA) be allowed to perform research on marijuana’s many terpenes and cannabinoids.
Potentially aiding America’s veterans suffering from chronic pain and posttraumatic stress disorder (PTSD), Walz sent a request to VA Secretary David Shulkin on Oct. 26 in the form of a letter; asserting the veterans administration “is uniquely situated to pursue research on the impact of medical marijuana on veterans suffering from chronic pain and PTSD.”
Walz was joined in signing the letter by Reps. Mark Takano (D-CA), Julia Brownley (D-CA), Ann Kuster (D-NH), Beto O’Rourke (D-TX), Kathleen Rice (D-NY), J. Luis Correa (D-CA), Kilili Sablan (I-Northern Mariana Islands), Elizabeth Esty, (D-CT), and Scott Peters (D-CA).
History of Breakthroughs at the ORD
Since the VA first established its Office of Research and